Sorafenib-based therapy in HER2-negative advanced breast cancer: Results from a retrospective pooled analysis of randomized controlled trials

por TAN, QI-XING, QIN, QING-HONG, LIAN, BIN, YANG, WEI-PING, WEI, CHANG-YUAN
Publicado 2014

IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis

por Liao, Jian, Qin, Qing-hong, Lv, Fa-you, Huang, Zhen, Lian, Bin, Wei, Chang-yuan, Mo, Qin-guo, Tan, Qi-xing
Publicado 2023